Methenolone Enanthate (Primobolan E) - Pharmacological & Analytical Intelligence Portal
AAS-ANALYSIS

Methenolone Enanthate (Primobolan E)

Pharmacological, Clinical & Forensic Intelligence Dashboard

Executive Summary & Compound Profile

This interactive intelligence platform provides a comprehensive breakdown of Methenolone Enanthate (commercially known as Primobolan Depot or Primobolan E), a synthetic 5α-dihydrotestosterone (DHT) derivative engineered in 1962. Designed to maximize muscle anabolism while mitigating virilization and androgenic side effects, methenolone occupies a unique position in clinical medicine, sports science, and forensic toxicology. Explore structural modifications, dual-receptor binding kinetics, organ toxicity, anti-doping detection windows, and counterfeit risk dynamics below.

Formula C₂₇H₄₂O₃ CAS: 303-42-4
Molecular Weight 414.63 g/mol Exact Mass: 414.3134
Active AAS Ratio 0.73 (73%) 27% Heptanoic Acid
Half-Life 10.5 Days Intramuscular Depot
Aromatization 0% (None) 5α-Reduced Base
Detection Window 4–5 Months LC-HRMS Sulfate LTM
⚗ Molecular Architecture

Methenolone utilizes a 1-methyl group paired with a Δ¹ double bond to create a flattened A-ring. This steric alteration prevents deactivation by skeletal muscle 3α-HSD while blocking aromatization via CYP19A1.

⚠ Toxicology & Tendons

Despite low hepatotoxicity (lacking 17α-alkylation), methenolone causes severe HDL collapse, arterial stiffening, and a fatal connective tissue paradox: upregulating collagen volume while inhibiting cross-linking, driving tendon avulsions.

🔬 Anti-Doping Breakthroughs

WADA anti-doping laboratories replaced short-term glucuronide testing with LC-HRMS sulfo-conjugated Long-Term Metabolites (LTMs) and Dried Blood Spot (DBS) ester detection, expanding the retrospectivity window from weeks to 150+ days.

Clinical Legacy & The Duchess Cocktail

Therapeutic Medical Applications (1962–1990s)

Methenolone was introduced by Squibb (Nibal Depot) and commercialized globally by Schering (Primobolan Depot). It was clinically deployed for:

  • Aplastic Anemia & Bone Marrow Failure: Direct stimulation of erythroid stem cells and renal EPO transcription.
  • Osteoporosis & Fracture Healing: Upregulating osteoblast activity and serum alkaline phosphatase (ALP).
  • Prophylaxis in MRONJ: Improving local angiogenesis and osteoblast survival in maxillofacial surgery.
  • Palliative Breast Cancer: Estrogen-independent suppression of malignant tissue prior to modern SERMs.

Illicit Athletic Dominance & Anti-Doping Focus

Revered as "Primo" in bodybuilding for producing a "dry, hard" look without fluid retention, methenolone gained infamous global attention in state-sponsored doping regimens:

  • Russian "Duchess Cocktail": A sublingual mixture of Methenolone, Oxandrolone, and Trenbolone dissolved in alcohol for rapid mucosal absorption and minimal detection window during the 2014 Sochi Winter Olympics.
  • High Market Counterfeit Rates: Due to complex chemical synthesis, UGL (Underground Lab) samples are routinely adulterated with cheap testosterone or methandienone, causing severe unexpected estrogenic crises.

Methenolone Enanthate Scientific, Clinical & Anti-Doping Intelligence Portal © 2026

Strictly for academic, analytical, and educational purposes. Not intended as medical advice or endorsement of controlled substances.

©Copyright 2026 PED Test New Zealand

Returns and Refunds | Terms and Conditions | Privacy Policy | Shipping Policy